Maximilian Wiendl



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Discrepant Phenotyping of Monocytes Based on CX3CR1 and CCR2 Using Fluorescent Reporters and Antibodies (2024) Sommer K, Garibagaoglu H, Paap EM, Wiendl M, Müller T, Atreya I, Krönke G, et al. Journal article Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells (2024) Wiendl M, Dedden M, Liu L, Schweda A, Paap EM, Ullrich K, Hartmann L, et al. Journal article Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease (2023) Schulze L, Becker E, Dedden M, Liu L, Van Passen C, Mohamed Abdou M, Müller T, et al. Journal article Anti-beta 7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing (2023) Sommer K, Heidbreder K, Kreiß L, Dedden M, Paap EM, Wiendl M, Becker E, et al. Journal article, Original article Nr4a1-dependent non-classical monocytes are important for macrophage-mediated wound healing in the large intestine (2023) Heidbreder K, Sommer K, Wiendl M, Müller T, Atreya I, Hildner K, Neurath M, Zundler S Journal article Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets (2023) Dedden M, Wiendl M, Müller T, Neurath M, Zundler S Journal article Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells (2022) Schweda A, Becker E, Wiendl M, Atreya R, Atreya I, Müller T, Neurath M, Zundler S Journal article Residual homing of alpha 4 beta 7-expressing beta 1(+)PI16(+) regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab (2021) Becker E, Dedden M, Gall C, Wiendl M, Ekici AB, Schulz-Kuhnt A, Schweda A, et al. Journal article Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy (2021) Wiendl M, Becker E, Müller T, Voskens C, Neurath M, Zundler S Journal article, Review article Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 (2021) Müller T, Becker E, Wiendl M, Schulze L, Voskens C, Kremer A, Neurath M, et al. Journal article
1 2 3